SCHEMBL25096019

SCHEMBL25096019

CN1CC(CC(=O)C(C)(C)C)C1

nearest known ligand 0.34

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
LIPA P38571 1/20 0.34
BRD4 O60885 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25096022 0.86 NCF1 (0.38) LIPA
SCHEMBL25095587 0.83 SMN1; SMN2 (0.41)
SCHEMBL19169454 0.79 NCF1 (0.43) LIPA
SCHEMBL18751697 0.77 LIPA (0.38) LIPA
SCHEMBL8406312 0.77 LIPA (0.52) LIPA
SCHEMBL3421354 0.77
Hydrochloric Acid SCHEMBL18979999 0.75 SLC6A12 (0.40)
SCHEMBL13885754 0.75
SCHEMBL25095612 0.74 NCF1 (0.38) LIPA
SCHEMBL9662429 0.73 LIPA (0.44) LIPA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230070613-A1 PROTEIN TYROSINE KINASE 6 (PTK6) DEGRADATION / DISRUPTION COMPOUNDS AND METHODS OF USE ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI 2023-03-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230070613-A1 PROTEIN TYROSINE KINASE 6 (PTK6) DEGRADATION / DISRUPTION COMPOUNDS AND METHODS OF USE PTK6, NEK6, GRK6 LIPA 4070/4885BRD4 1222/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.